Vijaya Diagnostics – Penetrating Home Markets; High Ebitda Margin To Sustain: Systematix


BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

We present key takeaways from our virtual conference on India’s diagnostics industry, where we hosted the management of Vijaya Diagnostics Centre Ltd.

The company remains focused on core geographies, and believes there is enough headroom for growth in the near term. At the same time, it is also investing in building the foundation for medium-to-long-term growth through hubs in nearby regions, to gradually expand presence over a larger area.

Vijaya Diagnostics continues to penetrate home markets of Hyderabad and Telangana. It is also looking to expand business in Kolkata with another hub center.

The management is confident of achieving 40% Ebitda margin on a sustainable basis, and revenue growth in mid-teens. Vijaya Diagnostics is well insulated from the hypercompetitive pathology market, as it enjoys meaningful contribution from the radiology segment.

Click on the attachment to read the full report:


This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.


Source link

What is your reaction?

In Love
Not Sure

You may also like

Comments are closed.

More in:Business